PharmaTher Holdings Ltd Com

News & Events

Press Releases

In The Media

1. PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market

   GlobeNewswire JUN 24, 2025 8:00 AM EDT
   TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("...
   READ ARTICLE

2. PharmaTher Applauds FDA's New Commissioner's National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications

   GlobeNewswire JUN 18, 2025 8:00 AM EDT
   TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("...
   READ ARTICLE

3. PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

   GlobeNewswire MAY 16, 2025 8:00 AM EDT
   TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("P...
   READ ARTICLE

4. PharmaTher Unveils KetaVault(TM): A First-of-Its-Kind Portal to Accelerate Ketamine Research and Commercialization

   GlobeNewswire MAY 14, 2025 8:00 AM EDT
   TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” o...
   READ ARTICLE

5. PharmaTher Receives US FDA Approval Goal Date for Ketamine

   GlobeNewswire MAR 11, 2025 8:00 AM EDT
   TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company”...
   READ ARTICLE

6. PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine

   Newsfile MAR 3, 2025 8:00 AM EST
   Expecting FDA approval of Ketamine in Q2-2025 Solving the shortage problem of Ketamine and unl...
   READ ARTICLE

7. PharmaTher Provides Update on FDA New Drug Application for Ketamine

   GlobeNewswire FEB 12, 2025 8:00 AM EST
   TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” ...
   READ ARTICLE

8. PharmaTher CEO Issues Letter to Shareholders

   GlobeNewswire JAN 6, 2025 8:00 AM EST
   TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” ...
   READ ARTICLE

9. PharmaTher Announces Grant of Stock Options

   GlobeNewswire JAN 3, 2025 5:15 PM EST
   TORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” ...
   READ ARTICLE

10. PharmaTher Announces Update on FDA New Drug Application for Ketamine

    GlobeNewswire NOV 26, 2024 8:00 AM EST
    FDA provided preliminary responses to questions contained in the clarification only post-CRL meet...
    READ ARTICLE